Baltimore Project Aims to
Decrease HIV in Nigeria
|
Dr. William Blattner (Newsline
photo by Nikole Albowicz)
|
By Nikole Albowicz
Maryland Newsline
Friday, April 23, 2003
BALTIMORE - Dr. William Blattner sees a devastating similarity between
Baltimore and Nigeria: unbelievably high rates of HIV.
But Blattner, a professor and associate director at the Institute of Human
Virology, hopes to turn that negative connection into something positive. He
hopes that by working together, Baltimoreans and Africans can learn ways to lower
the number of HIV infections in both places.
Blattner's vehicle to accomplish this difficult task is the University
Technical Assistant Program, in which institute faculty offer advice and training on HIV prevention and treatment techniques to
the Nigerian government and medical community.
"There is no doubt of the importance of a program that deals with HIV
in Africa," says Boliji Adebiyi, deputy information attache for the Nigerian
Embassy in Washington, D.C. "It's a welcome development. I'm
sure it will be a tremendous help to Nigerians in educating them on HIV."
Battling Drug Resistance and Newborn Infections
Armed with a five-year, $4.4 million grant from the Centers for Disease
Control and Prevention, Blattner and his colleagues will focus on helping
Nigerian officials combat drug resistance and halt transmissions of
the virus from mother to child.
Avoiding resistance to drugs used to fight HIV-- something that experts in the United States failed to
do --is a major goal. Ten percent to 15 percent of all new HIV
infections in Baltimore involve a drug-resistant virus, Blattner says.
Resistance occurs when drug levels decrease in the body and the virus, which is no
longer suppressed, mutates, Blattner says. It can happen when
patients participate in multiple drug therapies or take drugs
inconsistently, he says. The mutated, drug-resistant version of HIV soon emerges as the
dominant virus in the body.
"Large-scale application of antiretroviral drugs, if not properly planned
and monitored, can result in drug resistance and treatment failures,"
says
Dr. Johnson Onoja, a Fogarty International Center trainee from Nigeria who
is working at the institute.
As part of the program, experts from the institute will work with Nigerian
officials to educate patients
about HIV medications, Blattner says. Institute faculty will also work to ensure that patients
in Nigeria take their medications
consistently.
"The goal that we have is to try and learn from some of the mistakes that
we've made," Blattner says.
Staff will also educate Nigerian officials on techniques to prevent mothers
from transmitting HIV to their newborns, such as promoting safe sex and
encouraging use of bottled
milk rather than breastfeeding, Blattner says.
In Africa, more than one in
three children will become infected with HIV before their first birthday,
according to institute’s 2001-2002 annual report.
“If you were married and were going to have a child and you were looking at
the probability of hopelessness of bringing a child into the world with the
prospects that they’re going to die at a young age from this virus, then you
would feel very strongly that this is something that has to stop,” he
says.
The War on AIDS vs. the War in Iraq
About 20 people from the institute are working on the project, along
with five CDC officers (two in Nigeria), Blattner says.
Each of the four Nigerian Centers of Excellence, which are located in Benin,
Kano, Abuja and Nnewi, has two leaders and will eventually have a staff of
at least 20.
2001 HIV/AIDS Statistics |
Area |
People Living with HIV/AIDS |
Baltimore City |
12,292 |
Maryland |
24,200 |
Nigeria |
3,500,000 |
Sub-Saharan Africa |
28,000,000 |
SOURCES: The Maryland AIDS
Administration and UNAIDS |
Teams from the institute, usually made up of two
people, travel to Nigeria on a rotating basis to work on the project.
Faculty made their first visit to the African country in January. The last
group to visit Nigeria returned home about two and a half months ago.
But the U.S.-led war on Iraq is slowing down the progress of the program,
which began in November 2002 and is still in the early stages.
A decision was made to suspend travel to Nigeria due to instability of
the region right now, Blattner says.
"So unfortunately, world events slow down our fight against AIDS."
But
Blattner says a Nigerian team scheduled to come to the United States and
meet with staff at the institute in early May still plans to make its trip.
Once travel resumes, some staff members will continue to rotate visits in
shifts that last from 10 days to two weeks, while others may stay for longer
periods, Blattner says.
Onoja says that researchers need to note differences in American and
Nigerian cultures, such as attitudes toward superstitions. These factors, if not taken into consideration, may pose challenges to
acceptance of the program, he says.
But Blattner is confident that the program will be a success. He even
speculated that it could result in new techniques to fight HIV that could be
used in the United States.
"There's an opportunity to learn both ways," he says.
Copyright ©
2003
University of Maryland
Philip Merrill College of
Journalism
Top of Page | Home Page
|